Visit Bulgaria
Visit Bulgaria
... losses earlier this month narrowing down to $10.5-million. Biodel's shares gaining 1.7% to $4.20, in after-hours trading, had fallen 14% during the year.
and more »
Thursday, December 31, 2009
Biodel Submits Viaject New Diabetes Drug For FDA Approval - Visit Bulgaria
Visit Bulgaria
Visit Bulgaria
... losses earlier this month narrowing down to $10.5-million. Biodel's shares gaining 1.7% to $4.20, in after-hours trading, had fallen 14% during the year.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment